Too Much Buzz over that Study About Eating Fish and MS?
I’m not a fish eater. I never have been. Unless the seafood is lobster, shrimp, clams, or crab cakes (pickin’ the crabs is too much work), I’m not interested. Is the fact that…
The MS Wire — Ed Tobias
People say to write what you know and Ed Tobias knows about MS. He’s lived with the illness since 1980, when he was 32 years old. Ed’s a retired, award-winning broadcast journalist and his column combines his four decades of MS experiences with news and comments about the latest in the MS community. In addition to writing his column, Ed is one of the patient moderators on the MS News Today Facebook, Twitter, and Instagram sites. He’s also the author of “The Multiple Sclerosis Toolbox: Hints and Tips for Living with M.S.” Ed and his wife split their time between the Washington, D.C. suburbs and Florida’s Gulf Coast, trying to follow the sun.
Featured Post
After more than 7 years, ‘The MS Wire’ column is moving on
This is my 823rd column for Multiple Sclerosis News Today. It is also my last. Over the past seven and a half years, I’ve written about multiple sclerosis (MS) fatigue and…
Read more
MS Can Be a Kids’ Disease, Too (Part 2)
After I wrote about pediatric MS earlier this month, a reader commented: “I think it would behoove your editorship to follow up to address to audiences…symptoms that typify the early-age demographic.” That’s…
MS News that Caught My Eye Last Week: Zinbryta, Fish Oil, MS Associate Certification, Blood-brain Barrier
Biogen and AbbVie Voluntarily Withdraw Marketing Authorizations for MS Therapy Zinbryta You may have heard about this already, so forgive me if it’s not new to you, but it’s…
Getting Cash Back for Choosing Medical Services
You know about credit cards that offer you cash back for the items you buy. How about getting cash back for selecting specific healthcare service providers for things like medical tests and…
MS Can Be a Kids’ Disease, Too
The age at which a person is diagnosed with MS is usually between 20 and 50, according to the National Multiple Sclerosis Society. But it can be diagnosed in people much younger.
MS News that Caught My Eye Last Week: Epstein-Barr Virus, Gilenya, Naltrexone, Medical Marijuana
Epstein-Barr Virus Found in Brain Cells of Many MS Patients, Study Reports This study is yet another of several over the years that have suggested that there’s some sort of…
What’s Hot and What’s Not Among MS Therapies?
The newest kids on the MS block, disease-modifying therapies (DMT) such as Genentech’s Ocrevus (ocrelizumab) and Sanofi Genzyme’s Lemtrada (alemtuzumab), are attracting a lot of interest these days. But, some DMTs that have…
MS News that Caught My Eye Last Week: Mediterranean Diet, Medical Marijuana, Ocrevus, Myelin Repair
Pilot Study Is Testing Whether Mediterranean Diet Can Help MS Patients There’s been a good deal of news recently about the possibility that bacteria in our stomachs have an impact on…
How Bad Are Proposed Changes to the Americans with Disabilities Act?
My knee was jerking the other day. It wasn’t my MS, it was my knee-jerk reaction to the passage in the U.S. House of Representatives of a bill called the ADA Education…
Looking for Healthcare Answers on the Internet Can Drive You Nuts
I know, I know. I write about health issues on the internet, so I shouldn’t be discouraging people from looking for answers here. But, searching the internet to match symptoms with…
MS News that Caught My Eye Last Week: Stem Cell Trial, Medical Marijuana, Myelin Repair, Tysabri Study
Stem Cell Treatment Benefits Three-fourths of MS Patients in Phase 1 Trial This is encouraging news for MS patients hoping to see some action in the stem cell area. A Phase…
Peeking Behind the Curtain at Medical Insurance Decisions
Several years ago, I tried to get my insurance company to approve a functional electronic stimulator (FES). It’s a durable medical device that significantly improved my left foot drop. My request…
Where Are the Handicapped Parking Spots?
It’s nice when a negative experience can be turned into one that’s positive. I think that’s the result for a wheelchair-using MS patient following a problem she had at the Mall of America…
MS News that Caught My Eye Last Week: 3rd Round of Lemtrada, Ampyra’s Possibilities, Long-term MD1003, Possible PML Treatment
#ACTRIMS2018 – Third Course of Lemtrada Improves Relapse, Disability in MS Patients, CARE-MS II Trial Shows The normal treatment regimen with Lemtrada is a series of two treatment courses, with the second infusion…
Good News for Tysabri Users Who Are JCV Positive
One of the many disease-modifying therapies (DMTs) that I’ve been on over the many years of my treatment for MS is Tysabri (natalizumab). It worked well, holding the progression of my MS at…
Is It Time to Change Your MS Doctor?
The other day, as I cruised around various MS internet groups, I came across a lament that I’ve seen before. But this one, for some reason, jumped out at me. A woman with…
MS News that Caught My Eye Last Week: Testosterone and MS, Ocrevus in the UK, Enhanced MRI Technology, Ublituximab Trial Results
Researchers Identify Testosterone-triggered Molecule That Protects Men From MS This finding is an extension of research that has already indicated that a higher testosterone level reduces the chance…
Affording Your MS … or Not, You’re Likely Paying Either Way
Have you been in this Catch-22? You had great medical insurance when you were working. But, you’re not working anymore. Your insurance now comes with a $6,000 deductible and it doesn’t cover any…
The Big Pharma-Government Revolving Door Is Spinning
You may have heard that there’s a new secretary of Health and Human Services (HHS) in the United States. HHS is the department that guides the nation’s healthcare programs and policy, and the…
MS News that Caught My Eye Last Week: Medical Marijuana Gum, Brain Stimulation and Fatigue, Gilenya Study, Invisible Diseases
Holland Approves Clinical Trial Plans for AXIM’s Cannabis-based Gum for MS Pain and Spasticity Because the state where I live has only recently approved the use of medical marijuana, I haven’t…
